
Category: Healthcare
-

Date:
Lyme Disease Treatment Market Strengthened by Rising Disease Prevalence, Hitting USD 3 Billion by 2031
The Lyme Disease Treatment Market is experiencing steady growth due to the rising prevalence of tick-borne infections worldwide. Lyme disease is caused…
-
Date:
CBD Hemp Oil Market Set to Surpass USD 2.5 Billion by 2026 Amid Rising Demand for Natural Therapeutics
The global CBD hemp oil market is witnessing remarkable expansion, driven by increasing awareness of natural and plant-based therapeutics across the healthcare…
-

Date:
ACL Reconstruction Procedures Market Size Forecast to USD 11.5 Billion by 2031 with Rising Sports Injuries and Orthopedic Surgeries – Analysis by Transparency Market Research
ACL Reconstruction Procedures Market Outlook 2031 The global ACL reconstruction procedures market was valued at USD 6.8 Billion in 2020 and is…
-

Date:
Patients with High sRAGE Levels at Risk for COVID-19 Morbidities Driving Advanced Glycation End Products Market Growth to USD 2.76 Billion by 2031 at 5.4% CAGR
The global advanced glycation end products (AGEs) market is witnessing steady expansion, driven by rising incidences of chronic diseases and increasing awareness…
-

Date:
Veterinary Dermatology Drugs Market Gains Momentum Amid Rising Pet Ownership and Increasing Skin Disease Cases in Animals
The global veterinary dermatology drugs market was valued at over US$ 3.6 billion in 2020 and is projected to expand at a…
-

Date:
Rare Dermatological Disease Treatment Market to Grow at 4.9% CAGR Through 2031
The rare dermatological disease treatment market is projected to grow steadily, registering a CAGR of 4.9% during the forecast period from 2021…
-

Date:
Acute Exacerbation of CRS Treatment Market to Reach USD 7.06 Billion by 2031, Driven by Rising Disease Burden at 4.6% CAGR
The Acute Exacerbation of Chronic Rhinosinusitis (CRS) Treatment Market represents a crucial segment within the respiratory and ENT therapeutics landscape. Acute exacerbation…
-

Date:
Generic Injectables Market to Surpass US$ 307.7 Billion by 2031, Growing at 12.3% CAGR | TMR
The global generic injectables market has emerged as a critical pillar of the pharmaceutical industry, driven by the rising demand for cost-effective…
-

Date:
Acute Graft Versus Host Disease [GvHD] Treatment Market Set to Reach US$ 634.3 Mn by 2031 Driven by Ruxolitinib Adoption and Advancements in Targeted Therapies
The global acute graft versus host disease (GvHD) treatment market is projected to reach US$ 634.3 Mn by 2031, expanding at a…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.


